In the complex fabric of human society, commercial activities have become undeniably pervasive, shaping countless aspects of daily life, including health outcomes. The interplay between commerce and health has traditionally been viewed through the lens of opportunity and benefit; however, a growing body of research highlights a critical yet often overlooked balance—the parallels of benefit and harm embedded within these commercial influences. This dynamic is particularly pronounced in the sphere of maternal health, where the commercial determinants that work silently behind the scenes wield considerable influence. A recent groundbreaking study published in npj Women’s Health extends our understanding by dissecting how these commercial determinants adversely impact maternal well-being and why addressing them transcends health advocacy—it is a moral imperative deeply entwined with social justice, equity, and sustainable development.
Maternal health occupies a unique position within public health due to its intrinsic connections with generational well-being and social progress. Despite significant advances in maternal care and policy, disparities remain stubbornly persistent, often reflecting underlying societal inequities. Historic gender inequities have systematically marginalized mothers, limiting their agency and amplifying their vulnerability to harmful commercial practices. These range from aggressive marketing of formula milk circumventing breastfeeding norms to commodification of reproductive health services, all of which contribute to poorer health outcomes. This intersection of commerce and gender inequity lays bare the structural challenges that impede mothers from accessing and exercising autonomy in health-related decisions.
Understanding the commercial determinants of maternal health requires a multilayered analysis of the economic forces, industry practices, and regulatory environments that combine to influence maternal well-being globally. Commercial determinants encompass not only the direct products and services marketed to expectant and new mothers but extend to the broader economic ecosystem that includes employment conditions, access to social protections, and environmental exposures shaped by commercial enterprise. These determinants often shape risks in insidious ways, embedding themselves into cultural norms and healthcare infrastructure, making their identification and mitigation a daunting yet necessary task.
.adsslot_DiRL4xd7ys{width:728px !important;height:90px !important;}
@media(max-width:1199px){ .adsslot_DiRL4xd7ys{width:468px !important;height:60px !important;}
}
@media(max-width:767px){ .adsslot_DiRL4xd7ys{width:320px !important;height:50px !important;}
}
ADVERTISEMENT
One of the critical dimensions addressed in the recent research is how multinational corporations exploit gaps in regulation and societal vulnerabilities to promote products that undermine maternal health. For instance, the marketing strategies of formula companies in low- and middle-income countries often disregard international codes that safeguard breastfeeding practices, exacerbating risks such as infections and malnutrition in infants. Beyond infant formula, the commercialization of fertility treatments or prenatal supplements raises ethical questions around profiteering versus genuine health promotion, with disparities evident in access and information dissemination.
Moreover, labor market dynamics influenced by commercial interests pose significant health risks to mothers. Precarious employment, low wages, and lack of maternity protections are direct consequences of economic models valuing profit maximization over worker well-being. These conditions limit mothers’ ability to seek timely prenatal care, maintain nutrition, and avoid stressors detrimental to pregnancy outcomes. In many regions, commercial pressures on healthcare delivery systems push services towards privatization and cost-cutting, diminishing quality and accessibility, disproportionately affecting the most vulnerable populations.
Environmental risks—another domain driven by commercial activities—add an additional layer of complexity. Mothers are uniquely susceptible to exposures such as air and water pollution, toxic substances, and chemical contaminants linked to industrial and agricultural operations. These exposures are often compounded by poverty and inadequate healthcare, intensifying adverse maternal and fetal health outcomes. The commercial imperative driving environmental degradation thus intersects with gender and socio-economic inequities, crafting a potent threat matrix to maternal health.
Addressing these commercial determinants necessitates integrated, cross-sectoral approaches. Isolated public health interventions risk futility if systemic commercial drivers remain intact. Regulatory reforms targeting marketing, labor rights, environmental standards, and healthcare access must be harmonized with gender-equitable policies and community empowerment frameworks. Recognizing commercial determinants as a priority issue transforms maternal health advocacy into a broader movement aligned with social justice, economic policy reform, and sustainable development goals.
A moral dimension underpins the imperative to tackle commercial determinants in maternal health. Ethical stewardship demands that society does not tolerate forces compromising the fundamental rights of mothers to health, dignity, and informed choice. These rights must be foregrounded in global policy dialogue, transcending national boundaries and economic agendas. The study underscores that prioritizing mothers’ health in the face of commercial pressures is not merely a health sector concern but a fundamental reflection of societal values and commitments.
The implications extend far beyond individual health. Maternal health is a cornerstone of human potential, influencing childhood development, educational attainment, and economic productivity. When commercial determinants degrade maternal well-being, they set off a cascade of negative outcomes across communities and generations. Conversely, mitigating these harms fosters resilient, equitable societies where social, economic, and environmental potentials can flourish. Therefore, public health interventions must embrace systemic change, involving stakeholders from government, civil society, healthcare providers, and affected communities.
Technological innovations and data analytics offer promising tools for identifying and monitoring commercial influences on maternal health. Real-time data on product marketing, labor conditions, and environmental exposures can facilitate targeted interventions and accountability mechanisms. However, technology alone cannot supplant the need for political will, advocacy, and grassroots mobilization to confront entrenched commercial interests and structural inequities.
International frameworks, such as the World Health Organization’s code on marketing breastmilk substitutes, represent critical benchmarks but face enforcement challenges. Strengthening global governance and cooperation can amplify these instruments’ effectiveness. Simultaneously, empowering mothers through education, legal protections, and economic support strengthens their agency, enabling informed decisions resistant to harmful commercial pressures.
The COVID-19 pandemic has further highlighted the vulnerabilities of maternal health systems under commercial strain, as economic disruptions and service constraints magnified exposure to adverse determinants. Recovering from the pandemic provides an impetus to reimagine maternal health within a framework that fully integrates commercial determinants into health planning and policy, ensuring resilience against future shocks.
In conclusion, the burgeoning recognition of commercial determinants as fundamental drivers in maternal health marks a paradigm shift in public health thinking. It calls for comprehensive, ethically grounded, and multisectoral responses to safeguard mothers from the harms hidden within the vast expanse of global commerce. As the study articulates, prioritizing this agenda is not only necessary but urgent to unlock the full spectrum of human social, economic, and environmental potential. This transformative perspective reaffirms maternal health as a linchpin in achieving a just, sustainable future.
Subject of Research:
The study investigates the adverse impact of commercial determinants on maternal health, emphasizing historic gender inequities and the necessity for integrated policy and social action.
Article Title:
The commercial determinants of maternal health.
Article References:
Hanson, M., Bustreo, F., Di Renzo, G.C. et al. The commercial determinants of maternal health.
npj Womens Health 3, 44 (2025). https://doi.org/10.1038/s44294-025-00090-y
Image Credits: AI Generated
Tags: aggressive marketing in healthcarecommercial determinants of healthcommodification of reproductive servicesethical implications in maternal healthgender inequities in maternal careimpact of commerce on healthmaternal health advocacymaternal health disparitiesmaternal well-being and equitypublic health and commercesocial justice in maternal healthsustainable development and health
